ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab
Clinical trial NCT02296424 · COMPLETED
Trial details
- NCT number
- NCT02296424
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-17
- Primary completion
- 2016-10-14
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.